Updated Results on Modakafusp Alfa (TAK-573) Safety and Efficacy; Phase 1/2 Study of RRMM Patients

TAK-573 - Modakafusp alfa - Multiple Myeloma Clinical Trials

RVd Alone vs Rvd Plus ASCT in Newly Diagnosed Patients

Immunocytokine Therapy International Myeloma Foundation

Diagnosis and Therapeutic Advances in Multiple Myeoma

ctDNA Analysis and Relapse Association in Primary RRMM Patients Receiving Secondary Salvage Therapy

Updated Results on Modakafusp Alfa (TAK-573) Safety and Efficacy

IMF Patient & Family Webinar 2023 - Understanding The New Myeloma

ACCP Abstract Booklet - 2022 - Clinical Pharmacology in Drug

Efficacy and Safety of Tocilizumab for the Treatment of Systemic

Diagnosis and Therapeutic Advances in Multiple Myeoma

Immunocytokine Therapy International Myeloma Foundation

ASH highlights 2022—multiple myeloma